MeSH term
Frequency | Condition_Probility | Adolescent | 5 | 0.0 |
Adult | 15 | 0.0 |
Age of Onset | 4 | 0.0 |
Aged | 5 | 0.0 |
Child | 4 | 0.0 |
Cohort Studies | 2 | 0.0 |
*Drosophila Proteins | 2 | 0.0 |
Electron Transport Complex II | 7 | 26.0 |
Female | 13 | 0.0 |
*Germ-Line Mutation | 6 | 1.0 |
Heterozygote | 2 | 0.0 |
Hippel-Lindau Disease/genetics | 2 | 4.0 |
Humans | 39 | 0.0 |
Iron-Sulfur Proteins/*genetics | 2 | 22.0 |
Male | 14 | 0.0 |
Middle Aged | 11 | 0.0 |
Multienzyme Complexes/*genetics | 3 | 4.0 |
Multiple Endocrine Neoplasia Type 2a/genetics | 2 | 6.0 |
Mutation, Missense | 2 | 0.0 |
Oxidoreductases/*genetics | 3 | 3.0 |
Pheochromocytoma/*genetics | 8 | 19.0 |
Receptor Protein-Tyrosine Kinases/*genetics | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 23 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 13 | 0.0 |
Succinate Dehydrogenase/*genetics | 17 | 68.0 |
*Tumor Suppressor Proteins | 2 | 0.0 |
*Ubiquitin-Protein Ligases | 2 | 0.0 |
DNA Mutational Analysis | 10 | 0.0 |
Exons/genetics | 2 | 0.0 |
Genetic Screening | 3 | 0.0 |
Germ-Line Mutation/*genetics | 2 | 1.0 |
Haplotypes | 2 | 0.0 |
Head and Neck Neoplasms/*genetics | 3 | 4.0 |
Mutation, Missense/genetics | 3 | 1.0 |
Paraganglioma/*genetics | 7 | 46.0 |
Pedigree | 8 | 0.0 |
Polymerase Chain Reaction | 5 | 0.0 |
Prevalence | 2 | 0.0 |
Electron Transport | 3 | 4.0 |
Mitochondrial Diseases/*genetics | 2 | 22.0 |
Mutation | 6 | 0.0 |
Amino Acid Sequence | 10 | 0.0 |
Base Sequence | 11 | 0.0 |
Gene Expression | 2 | 0.0 |
Germ-Line Mutation/genetics | 2 | 2.0 |
Immunohistochemistry | 3 | 0.0 |
Loss of Heterozygosity/genetics | 2 | 1.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Adrenal Gland Neoplasms/genetics | 2 | 7.0 |
Head and Neck Neoplasms/genetics | 2 | 25.0 |
Membrane Proteins/*genetics | 4 | 0.0 |
Protein Subunits/*genetics | 7 | 36.0 |
Thyroid Neoplasms/genetics | 2 | 7.0 |
Animals | 10 | 0.0 |
Cloning, Molecular | 5 | 0.0 |
Molecular Sequence Data | 12 | 0.0 |
Paraganglioma/*enzymology/*genetics | 2 | 100.0 |
Sequence Alignment | 5 | 0.0 |
Succinate Dehydrogenase/chemistry/*genetics/metabolism | 2 | 50.0 |
Genetic Predisposition to Disease | 3 | 0.0 |
Germ-Line Mutation | 6 | 1.0 |
Penetrance | 3 | 2.0 |
Blotting, Southern | 2 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
Comparative Study | 5 | 0.0 |
Membrane Proteins/genetics | 3 | 0.0 |
Protein Subunits/genetics | 2 | 7.0 |
Carcinoma, Renal Cell/*genetics | 2 | 2.0 |
DNA Mutational Analysis/methods | 2 | 0.0 |
DNA, Neoplasm/genetics | 4 | 0.0 |
Kidney Neoplasms/*genetics | 2 | 0.0 |
Loss of Heterozygosity | 5 | 0.0 |
Polymorphism, Single-Stranded Conformational | 2 | 0.0 |
Succinate Dehydrogenase/genetics | 6 | 75.0 |
Exons | 2 | 0.0 |
Iron-Sulfur Proteins/biosynthesis/*genetics | 2 | 100.0 |
Sequence Homology, Amino Acid | 4 | 0.0 |
Cattle | 2 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
Promoter Regions (Genetics) | 3 | 0.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
Iron-Sulfur Proteins/genetics | 3 | 50.0 |
Macromolecular Substances | 2 | 0.0 |
Mice | 2 | 0.0 |
Adrenal Gland Neoplasms/*genetics | 5 | 16.0 |
Genetic Markers | 2 | 0.0 |
Neurofibromatosis 1/genetics | 2 | 6.0 |
Electron Transport/genetics | 2 | 28.0 |
Introns/genetics | 2 | 0.0 |
*DNA Methylation | 2 | 0.0 |
Chromosomes, Human, Pair 1/genetics | 2 | 1.0 |
Multienzyme Complexes/genetics | 2 | 8.0 |
Oxidoreductases/genetics | 2 | 5.0 |
Receptor Protein-Tyrosine Kinases/genetics | 2 | 1.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
